Abstract:Postbiotics, representing the newest member of the family of biotics, are metabolites produced as a result of fermentation of lactic acid bacteria (LAB) in the De Man, Rogosa, and Sharpe (MRS) medium which includes proteins, sugars and minerals. The components of postbiotics includes exopolysaccharides (EPS), short-chain fatty acids (SCFAs), bacteriocins, antioxidants, and metabolizing enzymes. Several studies indicate that postbiotics have multiple properties such as antimicrobial, immunomodulatory, antioxidant, anti-inflammatory, anti-obesity, anti-diabetic, and anti-tumoral properties. Natural polysaccharides refer to the polysaccharides obtained from biological organisms including algae, plants, animals, and microorganisms. Polysaccharides are either branched or linear macromolecules and are composed of a few major and some minor monosaccharides, including glucose, fructose, mannose, arabinose, galactose, fucose, galacturonic acid, glucosamine, galactosamine or their derivatives. Similar to postbiotics, polysaccharides also exhibit anti-inflammatory, antibacterial, antitumor, antiviral, immunomodulatory, and antioxidant properties. Although polysaccharides cannot be directly digested by the human body due to the lack of specific enzymes, they can be digested by gut-residing bacteria including but not limited to LAB. Recent studies indicate that large non-starch polysaccharides such as alginate, fucoidan, chitosan, carrageenan, and guar gum can be degraded into low molecular weight oligosaccharides which in turn can provide health benefits to the human health. These new findings inspired us to propose a polysaccharides-based postbiotics, also called glycanbiotics, and their potential applications. We propose that polysaccharides can be fermented by probiotics, and subsequent removal of bacteria will increase the safety of their produced metabolites, including oligosaccharides, disaccharides, monosaccharides and their derivatives. These polysaccharides-based postbiotics may mimic metabolization of polysaccharides in vitro and consequently broaden the applications of postbiotics. Non-probiotics such as Akkermansia muciniphila and other bacteria can also be used for glycanbiotics production, thus providing novel applications for human health.

Production of Natural Polysaccharides and Their Analogues via Biopathway Engineering

Remodeling Bacterial Polysaccharides by Metabolic Pathway Engineering

Enzymatic Synthesis Of Complex Bacterial Carbohydrate Polymers

Current Understanding on Biosynthesis of Microbial Polysaccharides

Enzymatic Synthesis of Oligosaccharides and Conversion to Glycolipids

In Vitro Reconstitution of A Bacterial Polysaccharide Biosynthetic Pathway

Enzymatic Biosynthesis of Oligosacch A Rides and Glycoconjugates

In Vitro Bacterial Polysaccharide Biosynthesis: Defining the Functions of Wzy and Wzz

Recent Advances in Chemical Synthesis of Polysaccharides

Microbial Production of Oligosaccharides and Polysaccharides

Biological strategies for oligo/polysaccharide synthesis: biocatalyst and microbial cell factory

Enzymatic Synthesis of Polysaccharide and Its Process Strengthening

Research Progress on Enzymatic Modification of Polysaccharides

Biocatalysts in Synthesis of Microbial Polysaccharides: Properties and Development Trends

Advanced strategies for metabolic engineering of Bacillus to produce extracellular polymeric substances

Research overview on the genetic mechanism underlying the biosynthesis of polysaccharide in tuber plants

Cell-based high-throughput screening of polysaccharide biosynthesis hosts

Natural Polysaccharides-Based Postbiotics and Their Potential Applications

Recent advances in polysaccharide biomodification by microbial fermentation: production, properties, bioactivities, and mechanisms.

Toward Automated Enzymatic Synthesis of Oligosaccharides.

The Preparation and Structure Analysis Methods of Natural Polysaccharides of Plants and Fungi: A Review of Recent Development